Retatrutide, from Soma, represents a significant advance in body control . This dual-action medication combines GLP-1 signaling function with another pathway stimulation , showing impressive efficacy in trial findings for weight loss . Researchers believe the drug is expected to offer a alternative pathway for individuals experiencing weight-relate